July 10, 2026
FORE Biotherapeutics
FORE Biotherapeutics raised $67.4 million in a Series D-2 extension financing round, bringing the total raised in the Series D-2 round to $110 million.
- Round
- Series D
- Amount raised
- $67.4M
- Lead investor
- —
- Industry
- biotechnology
- Headquarters
- Philadelphia, United States
- Employees
- 11-50 employees
- Website
- fore.bio
- View profile →
Source: Google Alerts